Market Overview

Benzinga's Top Downgrades

Related FINL
Athletic Footwear Sells Off Amid Signs Of Weakening Fundamentals
Mid-Day Losers From December 19: ImmunoGen, NQ Mobile And More
Finish Line 1Q Profit Doubles to Top Views (Fox Business)
Related ELN
Perrigo, Elan Receive Irish High Court Approval for Perrigo's Proposed Acquisition of Elan
Perrigo Shareholders Approve Acquisition Of Elan

Sterne Agee downgraded Finish Line Inc (NASDAQ: FINL) from “buy” to “neutral.” FINL's shares closed at $21.13 yesterday. Finish Line's trailing-twelve-month operating margin is 9.97%.

Analysts at UBS downgraded Elan Corporation plc (NYSE: ELN) from “buy” to “neutral.” ELN's shares closed at $14.50 yesterday. Elan's PEG ratio is -19.57.

RW Baird downgraded Amylin Pharmaceuticals Inc (NASDAQ: AMLN) from “outperform” to “neutral.” AMLN's shares closed at $27.44 yesterday. Amylin Pharmaceuticals' trailing-twelve-month ROE is -348.55%.

William Blair downgraded Booz Allen Hamilton Inc (NYSE: BAH) from “outperform” to “market perform.” BAH's shares closed at $16.86 yesterday. Booz Allen Hamilton's trailing-twelve-month profit margin is 3.57%.

Latest Ratings for FINL

DateFirmActionFromTo
Dec 2014Canaccord GenuityDowngradesBuyHold
Dec 2014Bank of AmericaDowngradesNeutralUnderperform
Dec 2014Bank of AmericaMaintainsNeutral

View More Analyst Ratings for FINL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AMLN + BAH)

Around the Web, We're Loving...

Get Benzinga's Newsletters